Tissue Imaging Market Size Forecasted to Reach Valuation of USD 27.32 Billion by 2027
The Global Tissue Imaging Market is estimated to reach USD 27.32 billion in 2027, up from USD 14.38 billion in 2019, showing a compound annual growth rate (CAGR) of 8.3 percent over the forecast period. Because of an increase in the number of people suffering from various chronic conditions, the market is witnessing strong demand. Worldwide, the increasing burden of various chronic diseases serves as a catalyst for the industry’s expansion. According to the World Health Organization, the incidence of chronic diseases will have increased by 57.0 percent by the end of 2020 compared to the year 2001. Various developing countries are particularly hard hit, with some accounting for as much as 60.0 percent of all chronic diseases in the world.
Rising healthcare spending and increased investment for healthcare research and development are both contributing to the market’s expansion. The total expenditure on healthcare in the United States reached USD 3.60 trillion in 2018, representing an increase of 4.6 percent over the previous year.
Now is the time to get your free sample PDF copy.
The Report’s most important findings and conclusions
- Abcam plc, a pharmaceutical firm based in the United Kingdom, announced an agreement with Visikol, a contract research organisation (CRO) specialising in drug discovery advancement, in March 2019 to collaborate on the development of new reagents and kits for improving tissue 3D clearing and imaging.
- In situ hybridization has a wide range of applications, including diagnostics and imaging of frozen tissues. It also has a large number of applications in immunohistochemistry, where it is used to perform comprehensive analysis of mRNA and protein.
According to the American Cancer Society’s statistics, men in the 65-year-old age bracket are 66.0 percent more likely than the general population to acquire prostate cancer. Furthermore, as the second most common disease in males in the United States, prostate cancer is a major cause of death among men in the United States.
- As a result of the widespread application of tissue imaging in the drug development process as well as the development of new analytical procedures, pharmaceutical companies held a significant part of the market in the year 2019.
Asia Pacific is experiencing rapid growth in the demand for tissue imaging procedures, which can be attributed to the rising incidence of infectious and chronic diseases, the mushrooming of industries such as biotechnology and pharmaceuticals, and the increase in several activities in research and development associated with tissue imaging procedures in the region.
- A number of major players in the sector include Abcam plc (formerly Bio-Rad Laboratories), Abbott Laboratories, Fluidigm Corporation, Becton, Dickinson and Company (formerly Becton Dickinson and Company), Agilent Technologies (formerly Danaher Corporation), Nikon Corporation (formerly Nikon Corporation), Biocare Medical (formerly Biocare Medical), and F. Hoffmann-La Roche Ltd. (formerly F. Hoffmann-La Roche Ltd.).
Technology, product, application, end-user, and geography are some of the ways in which Emergen Research has divided the global tissue imaging market, according to the company.
The Future of Technology (Revenue, USD Billion; 2017-2027)
Mass Spectroscopy is a type of spectroscopy that measures the amount of matter in a sample.
Flow Cytometry and Immunohistochemistry are two techniques used in cancer research.
Hybridization of Digital Pathology and In Situ Hybridization
Product Outlook for Immunofluorescence and Others (Revenue, USD Billion; 2017-2027)
Platforms Microscopes Consumables Software Accessories Application Outlook Platforms Microscopes Consumables (Revenue, USD Billion; 2017-2027)
Disease Research \sOncology Infectious Diseases are being researched. Investigate Neurological Disorders Cardiovascular Disease is something to look into. Immunological Diseases are being investigated. Research \sOthers
Diagnostics \sOncology Infectious Diseases Diagnosis and Treatment Neurological Disease Diagnosis and Treatment Cardiovascular Disease Diagnosis and Treatment Diagnostics \sImmunological Disease Diagnostics \sOthers
End-User Outlook (Revenue, USD Billion; 2017-2027) (Revenue, USD Billion; 2017-2027)
Hospitals and clinics Pharmaceutical companies Research institutes and other organisations Regional perspectives (Revenue, USD Billion; 2017-2027)
North America is a continent that includes the United States, Canada, and Mexico.
Europe as a whole
Asia and the Pacific
South Korea is a country in East Asia.
The rest of Asia-Pacific
Latin America is a continent that includes
The rest of Latin America
Africa and the Middle East
Saudi Arabia is a country in the Middle East.
UAE with the rest of the Middle East and North Africa
To learn more about top market solutions, please see the link below: